Follow
Sarah C Gilbert
Sarah C Gilbert
Professor of Vaccinology, Pandemic Sciences Institute, Oxford University
Verified email at ndm.ox.ac.uk
Title
Cited by
Cited by
Year
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
53782021
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
27952020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
16882020
Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant
SA Madhi, V Baillie, CL Cutland, M Voysey, AL Koen, L Fairlie, ...
New England Journal of Medicine 384 (20), 1885-1898, 2021
13882021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13542021
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
N Van Doremalen, T Lambe, A Spencer, S Belij-Rammerstorfer, ...
Nature 586 (7830), 578-582, 2020
11502020
Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera
D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (9), 2348-2361. e6, 2021
11452021
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
S Feng, DJ Phillips, T White, H Sayal, PK Aley, S Bibi, C Dold, M Fuskova, ...
Nature medicine 27 (11), 2032-2040, 2021
10672021
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
J Schneider, SC Gilbert, TJ Blanchard, T Hanke, KJ Robson, CM Hannan, ...
Nature medicine 4 (4), 397-402, 1998
8461998
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
H McShane, AA Pathan, CR Sander, SM Keating, SC Gilbert, K Huygen, ...
Nature medicine 10 (11), 1240-1244, 2004
7782004
Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ...
Cell 184 (16), 4220-4236. e13, 2021
7572021
Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria
C Ruwende, SC Khoo, RW Snow, SNR Yates, D Kwiatkowski, S Gupta, ...
Nature 376 (6537), 246-249, 1995
7531995
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7482021
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
SJ McConkey, WHH Reece, VS Moorthy, D Webster, S Dunachie, ...
Nature medicine 9 (6), 729-735, 2003
7132003
Antibody evasion by the P. 1 strain of SARS-CoV-2
W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (11), 2939-2954. e9, 2021
6662021
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ...
Nature medicine 27 (2), 270-278, 2021
6032021
Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera
P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (8), 2201-2211. e7, 2021
4912021
Upregulation of TGF-β, FOXP3, and CD4+ CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection
M Walther, JE Tongren, L Andrews, D Korbel, E King, H Fletcher, ...
Immunity 23 (3), 287-296, 2005
4722005
A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity
MDJ Dicks, AJ Spencer, NJ Edwards, G Wadell, K Bojang, SC Gilbert, ...
PloS one 7 (7), e40385, 2012
4132012
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ...
Nature communications 4 (1), 2836, 2013
3582013
The system can't perform the operation now. Try again later.
Articles 1–20